ArticleLife (Basel, Switzerland)2025

Early Real-World Outcomes of Switching to 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom.

Muiz Musadiq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.